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Abstract
This study examines the involvement of hormones and neuromediators in the regulation of Naq, Kq, Cly cotransport in
 2 .renal epithelial cells using Madin-Darby canine kidney cells with low transepithelial electrical resistance 194"47 Vrcm .
In this cell line, Naq, Kq, Cly cotransport measured as bumetanide-sensitive 86 Rb influx was inhibited up to 50–60% with
 .  .agonists of P -purinoceptors ATPfADP)UTP)AMP , slightly 15–30% increased by activators of cAMP signaling2
 .  .forskolin, 8-Br-cAMP and was insensitive to activators of cGMP signaling 8-Br-cGMP, nitroprusside , EGF, angiotensin
II, bradykinin, methacholine, propranolol, vasopressin, adenosine, dopamine and histamine. Thirty min of preincubation of
MDCK cells with 0.1 mM PMA completely blocked the activity of Naq, Kq, Cly cotransport whereas down-regulation of
this enzyme by 24 h of preincubation with 1 mM PMA activated Naq, Kq, Cly cotransport by 60% and abolished the effect
of short-term treatment with PMA. Regulation of Naq, Kq, Cly cotransport by ATP was insensitive to down-regulation of
PMA-sensitive isoforms of protein kinase C. In addition, an inhibitor of protein kinase activity, staurosporine, abolished the
effect of 0.1 mM PMA but did not change inhibition of this carrier by ATP. Thus, these results show for the first time that
P -purinoceptors and PMA-sensitive isoforms of protein kinase C play a key role in the regulation of Naq, Kq, Cly2
cotransport in MDCK cells. These results also show that neither PMA- nor staurosporine-sensitive forms of protein kinase
are involved in the inhibition of Naq, Kq, Cly cotransport by activators of P -purinoceptors. q 1998 Elsevier Science B.V.2
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1. Introduction
Twenty years ago, using microperfused tubule
preparations, it was established that the diuretic effect
 .of sulfamoylbenzoic acid derivates SAD is caused
by inhibition of transcellular movement of salt and
osmotically obliged water in the thick ascending limb
 . w xof Henle’s loop THAL 1,2 . Later on, it was shown
that SAD-sensitive ion transporter is operated as elec-
troneutral Naq, Kq, Cly cotransport with variable
stoichiometry and topology in different nephron seg-
 w x.ments for recent data, see 3,4 . The control of
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tubular reabsorption of salt and osmotically obliged
water is also variable along tubular segments. Thus,
in the collecting duct, cAMP directly increases the
number of functioning water channels in apical mem-
branes, the density of apical Naq channels and the
open probability of 35 pS Kq channels, whereas acti-
vation of protein kinase C-coupled signaling de-
creases the open probability of Naq channels and
q 35 pS ATP-sensitive K channels for review, see
w x. q q5 . Little is known about the regulation of Na , K ,
Cly cotransport in the mammalian kidney. It has
been shown that reabsorption of NaCl in the THAL is
w xstimulated by cAMP signaling 6 . However, the
relative contribution of Naq, Kq, Cly cotransport
and ion channels in this phenomenon is still a matter
w xof controversy 7–9 . The present study examines the
regulation of inward Kq fluxes in epithelial cells
 .derived from the canine kidney MDCK . Our results
indicate that in these cells, Naq, Kq, Cly cotransport
is completely inhibited by activation of protein kinase
 .C with 4ß-phorbol 12-myristate 13-acetate PMA ,
and partly by activation of P -purinoceptors. We also2
present evidence that inhibition of Naq, Kq, Cly
cotransport by P -purinoceptor agonists is not medi-2
ated by PMA-sensitive forms of protein kinase C.
2. Materials and methods
2.1. Cell culture
MDCK cells from the American Type Culture
 .Collection ATCC No. CCL 34 were used in this
study. MDCK cells seeded on permeable support
have a transepithelial resistance of 194"47 Vrcm2.
These results suggest that MDCK cells from our
stock have the properties of MDCK-strain II de-
w xscribed by Simmons 10 and clone C11 described by
w xGekle and co-workers 11 . In accordance with data
presented in the last paper, this substrain of MDCK
cells resembles intercalated cells of the collecting
duct. MDCK cells were incubated at 378C in a hu-
midified atmosphere of 95% air and 5% CO and2
grown in MEM Gibco Laboratories, Burlington,
.Canada , supplemented with sodium bicarbonate
2.5 grl, HEPES 2 grl, penicillin 100 Urml, strepto-
mycin 100 mgrml and 10% fetal bovine serum
 .Wisent, WI . The medium was changed 2–3 times
per week. The cells were passaged at subconfluent
density by treatment with 0.05% trypsin Gibco Lab-
. 2q 2qoratories in Ca - and Mg -free Dulbecco’s phos-
phate-buffered saline and scraped from the flasks
with a rubber policeman. Cells were counted with a
Coulter Counter. Dishes were inoculated at 1.25=
103 cellsrcm2. Both stock cultures and cultures for
experiments were grown for 6–8 days to attain sub-
confluency, in 80 cm2 culture flasks and 24-well
plates, respectively.
q (86 .2.2. Measurements of K Rb influx
q 86 .To study K Rb influx, MDCK cells were
washed twice with 2 ml of medium A containing
150 mM NaCl, 1 mM MgCl , 1 mM CaCl and2 2
10 mM HEPES–tris buffer pH 7.4, room tempera-
.ture and incubated for 30 min at 378C in 1 ml of
medium B with and without agents indicated in the
table and figures. Medium B contained: NaCl
140 mM, KCl 5 mM, MgCl 1 mM, CaCl 1 mM,2 2
D-glucose 5 mM, HEPES–tris 20 mM. Then, the
preincubation medium was replaced with 0.25 ml of
the same medium B with or without 1 mM ouabain
and 20 mM bumetanide. The cells were incubated at
378C for 5 min, and thereafter 0.25 ml of medium B
containing 1–2 mCirml 86RbCl was added. 86Rb up-
take was terminated by the addition of 2 ml of ice-cold
medium C containing 100 mM MgCl and 10 mM2
 .HEPES–tris buffer pH 7.4 . The cells were then
washed 4 times with 2 ml of ice-cold medium C and
lysed with 1 ml of 1% SDSr4 mM EDTA mixture.
The radioactivity of the cell lysate was measured
86  q.with a liquid scintillation analyzer. Rb K influx
was calculated as VsAramt where A is the ra-
 .dioactivity in the sample cpm , a is the specific
86  q.  .radioactivity of Rb K cpmrnmol in the incu-
 .bation medium, m is the protein content mg and t
 .is the incubation time min . Protein content was
w xmeasured by modified Lowry’s method 12 . In the
absence of ion transport inhibitors, the kinetics of
86 Rb uptake were linear up to at least 20 min Fig.
 ..1 A . Based on these findings, an incubation time of
15 min was used to determine the initial rate of Kq
influx.
2.3. Chemicals
PMA, 4a-PMA, bradykinin, norepinephrine, iso-
proterenol, ATP, AMP, 8-Br-cAMP, forskolin, argi-
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nine vasopressin, 8-Br-cGMP, ouabain, bumetanide,
furosemide were purchased from Sigma St. Louis,
.MO ; dopamine, methacholine, phenylephrine, UTP,
ADP, histamine from Research Biochemicals Interna-
 .tional Natick, MA ; angiotensin II from Armand-
 .Frappier Institute Laval, Canada ; epidermal growth
 .  .factor EGF from Gibco RBL Gaithersburg, MD ;
86  .RbCl from Dupont Boston, MA ; salts, D-glucose
and buffers were from Sigma and Anachemia
 .Montreal, Canada .´
2.4. Statistical analysis
Experimental manipulations were performed in tri-
or quadruplicate within any single experiment. The
results are given as means"standard errors. When
appropriate, statistical significance was assessed by
Student’s t-test for unpaired data. Differences of
p-0.05 were considered to be statistically signifi-
cant.
3. Results and discussion
The Naq, Kq pump and Naq, Kq, Cly cotrans-
port, identified as ouabain-sensitive and ouabain-re-
sistant bumetanide-sensitive 86Rb influx, respec-
tively, mediated ;65% and 30% of total Kq influx
  ..in MDCK cells Fig. 1 B . Both the absolute values
and relative activity of the Naq, Kq pump and Naq,
Kq, Cly cotransport were in accordance with previ-
w xously-reported data 13–17 . In the presence of 10 mM
bumetanide, 1 mM furosemide did not affect 86Rb
 .influx data not shown . It is known that at this
concentration, furosemide inhibits Naq-independent
q y w xK , Cl cotransport 18 . Thus, it may be concluded
 . qthat ouabainqbumetanide -resistant K influx, ac-
86   ..counting for about 5% of Rb influx Fig. 1 B ,
represents ion transport along its electrochemical gra-
dient via ion channels and leakage of the MDCK
membrane. We use the term ‘‘passive permeability’’
to combine these minor ion transport pathways.
Table 1 shows that an activator of protein kinase
C, PMA, completely blocked Naq, Kq, Cly cotrans-
port in MDCK cells, whereas ATP inhibited this
 .carrier by 50–60% p-0.001 . Activation of cAMP
signaling with 8-Br-cAMP, forskolin and cholera
toxin increased the rate of Naq, Kq, Cly cotransport
 .by ;20%, 30% and 60%, respectively Table 1 ,
whereas activation of cGMP signaling with 8-Br-
 .  .cGMP 1 mM or nitroprusside 1 mM did not affect
q q y  .Na , K , Cl cotransport data not shown . Both
q 86 .  . q q  86 . q q yFig. 1. Kinetics of K Rb influx A and activity of Na , K pump ouabain-sensitive Rb influx , Na , K , Cl cotransport
 86 . q  86 .  .ouabain-resistant, bumetanide-sensitive Rb influx and passive permeability for K ouabainqbumetanide-resistant Rb influx B
 .  .in MDCK cells. Means"S.E. obtained in 2 A and 20 B experiments performed in quadruplicate or triplicate are given.
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Table 1
Regulation of Kq influx in MDCK cells by activators of cAMP signaling, protein kinase C and ATP
q q y q q q .  .  .Addition Na , K , Cl cotransport % Na , K pump % Passive permeability for K %
 .None control 100 100 100
 .  .  .Forskolin, 10 mM 129"13 9 95"11 4 93"7 9
 .  .  .8-Br-cAMP, 1 mM 116"9 3 119"14 1 95"6 3
a .  .Cholera toxin, 0.5 mgrml 159"11 1 N.D. 98"9 1
d b .  .  .PMA, 0.1 mM 4"7 17 135"9 13 109"6 17
 .  .4a-PMA, 0.1 mM 120"8 1 N.D. 99"4 1
c a .  .  .ATP, 100 mM 43"8 11 130"8 5 103"6 11
Cells were preincubated for 30 min with forskolin, 8-Br-cAMP, PMA, 4a-PMA, ATP or for 3 h with cholera toxin before the
measurement of ion fluxes. Values of Naq, Kq, Cly cotransport, Naq, Kq pump and passive permeability for Kq in the absence of any
 .  .addition control were taken as 100%. Means"S.E. obtained in n experiments performed in quadruplicate are given.
a For p-0.05.
b For p-0.02.
c For p-0.001.
d For p-0.0001.
PMA and ATP activated the Naq, Kq pump by
 .  .20–40% p-0.02 and 0.05, respectively Table 1 .
We did not observe any significant effect of an-
 .  .giotensin II 1 mM , bradykinin 0.1 mM , vaso-
 .  .pressin 0.1 mM , epidermal growth factor 1 mM ,
 .  .adenosine 100 mM , dopamine 100 mM , histamine
 .  . q10 mM and methacholine 100 mM on K influx in
 .MDCK cells data not shown . Previously, it was
reported that in MDCK cells, PMA and dopamine
inhibit Naq, Kq-ATPase activity by 15–20% and
w x30–40%, respectively 15,19 . It should be empha-
sized, however, that crude membrane fractions of
MDCK cells were used to estimate the activity of this
enzyme in the above-cited studies.
Fig. 2 displays the dose-dependency of inhibition
of Naq, Kq, Cly cotransport by ATP, ADP, AMP
and UTP. The rank-order of potency revealed in this
 .study ATP;ADP)UTP4AMP suggests that
inhibition of Naq, Kq, Cly cotransport by these
compounds is mediated by P - or P -purinoceptors2X 2Y
w x20 .
The data listed below suggest that inhibition of
Naq, Kq, Cly cotransport by PMA is mediated via
activation of protein kinase C. Indeed, as seen in Fig.
3, half-maximal inhibition of Naq, Kq, Cly cotrans-
port was observed at 10 nM of PMA, which is in
accordance with data on the activation of protein
w xkinase C by this compound in intact cells 21 . The
inactive analogue of PMA, 4a-PMA, did not affect
q q y  .Na , K , Cl cotransport Table 1 . It was shown
that 24 h preincubation of epithelial cells with 1 mM
w xof PMA 22 or 3 mM of an analogue of PMA
 . w xPDBu 23 causes down-regulation of protein kinase
Fig. 2. Dose-dependence of Naq, Kq, Cly cotransport on nu-
cleotide concentrations. Cells were preincubated with nucleotide
for 30 min before the measurement of ion fluxes. Values of Naq,
Kq, Cly cotransport in the absence of nucleotide were taken as
100%. Means"S.E. obtained in experiments performed in quad-
ruplicate are given.
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Fig. 3. Dose-dependence of Naq, Kq, Cly cotransport on PMA.
Cells were preincubated with PMA for 30 min before the mea-
surement of ion fluxes. The value of Naq, Kq, Cly cotransport
in the absence of PMA was taken as 100%. Means"S.E. ob-
tained in experiments performed in quadruplicate are given.
C. In our study, treatment of MDCK cells with 1 mM
PMA for 24 h increased Naq, Kq, Cly cotransport by
 .50–70% Fig. 4 . This treatment completely abol-
ished the inhibition of this carrier by 0.1 mM PMA
 .Fig. 4 which suggests the down-regulation of
PMA-receptors. Neither the basal activity of Naq,
Kq, Cly cotransport nor its regulation by 0.1 mM
PMA was affected by long-term treatment with 4a-
PMA. A non-selective inhibitor of protein kinase
activity, staurosporine K 7, 9, and 0.7 nM for0.5
purified protein kinase A, G, and C, respectively
w x. q q y24 , decreased the activity of Na , K , Cl co-
 .transport by 33% Fig. 5 . In staurosporine-treated
cells, PMA did not significantly affect the activity of
this carrier. In contrast to the regulation by PMA,
neither staurosporine nor down-regulation of protein
kinase C affected the regulation of Naq, Kq, Cly
 .cotransport by ATP Figs. 4 and 5 .
Thus, data obtained in the present study demon-
strate for the first time that, in epithelial cells of the
Fig. 4. Effect of down-regulation of protein kinase C activity on
the regulation of Naq, Kq, Cly cotransport by PMA and ATP.
Cells were treated for 24 h with 1mM of PMA or 4a-PMA in
MEM containing 10% fetal calf serum. This medium was aspi-
rated, cells were washed twice with medium A and incubated for
30 min in medium B with or without 0.1mM PMA or 100 mM
ATP. The value of Naq, Kq, Cly cotransport in control cells
 .without PMA or ATP basal was taken as 100%. Means"S.E.
obtained in experiments performed in quadruplicate are given.
mammalian kidney, Naq, Kq, Cly cotransport could
be completely inhibited by PMA-sensitive forms of
protein kinase C and partly by agonists of P -purino-2
Fig. 5. Effect of staurosporine on the regulation of Naq, Kq, Cly
cotransport by PMA and ATP. Cells were washed twice with
medium A and incubated for 30 min in medium B. This medium
was then aspirated and cells were incubated for 10 min in 0.25 ml
of medium B with or without 0.5mM of staurosporine followed
by the addition of 0.25 ml of medium B with or without 0.1mM
PMA or 100 mM ATP. Then, cells were incubated for 30 min
before the measurement of ion fluxes. The value of Naq, Kq,
Cly cotransport in control cells without PMA, ATP or stau-
 .rosporine basal was taken as 100%. Means"S.E. obtained in
experiments performed in triplicate are given.
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ceptors. The regulatory properties of mammalian Naq,
Kq, Cly cotransport are extremely tissue specific.
Thus, cAMP signaling activates Naq, Kq, Cly co-
transport in the human intestinal secretory epithelium
w x w x25 , the shark rectal gland 26 , SV-40 transformed
w xcells derived from rabbit THAL 9 , and fetal human
w xnon-pigmental ciliary epithelial cells 27 . In contrast,
w xin the rat vascular smooth muscle 28,29 , monkey
w xretinal pigment epithelium 30 and human lympho-
w xcytes 31 , cAMP inhibits this carrier. In rat erythro-
w x w xcytes 32 and bovine tracheal epithelial cells 33 ,
SAD-sensitive ion fluxes are not affected by cAMP.
It has been reported that cGMP activates Naq, Kq,
Cly cotransport in neuroblastoma NB-OK-1 cells
w x w x34 , inhibits it in bovine endothelial cells 35,36 and
w xparathyroid cells 37 , and does not affect this carrier
in rat erythrocytes and vascular smooth muscle cells
w x28,32 . We did not observe any effect of PMA on
Naq, Kq, Cly cotransport in rat erythrocytes and
w xvascular smooth muscle cells 28,32 . In the rabbit
tracheal epithelium, PMA led to 10-fold activation of
q y w xSAD-sensitive Na and Cl effluxes 38 . In bovine
lens epithelial cells, Naq, Kq, Cly cotransport was
w xinhibited by PMA up to 50% 39 . However, in that
study, cells were treated with 10 mM PMA for 2 h,
whereas 1 h of treatment with 1 mM did not signifi-
cantly modify the activity of the carrier. Thus, it is
not clear whether the effect of 10 mM PMA was
caused by activation of protein kinase C, inactivation
of the enzyme due to down-regulation of its expres-
sion, or by a nonspecific action of the high PMA
concentration.
To our knowledge, there are no data on the inhibi-
tion of Naq, Kq, Cly cotransport by agonists of
w xP -purinoceptors. Middleton et al. 40 previously2
reported 2-fold stimulation of Naq, Kq, Cly cotrans-
port in ATP-treated A6 cells. These results are op-
posed to our data with a 2–3-fold decrease of Naq,
Kq, Cly cotransport in ATP-treated MDCK cells
 .Fig. 2 . However, we have to keep in mind that the
A6 cell line is derived from the amphibian kidney,
where renal anatomy and physiology are quite differ-
ent from that of the mammalian nephron. Data ob-
 .tained in the present study Fig. 4 show that PMA-
sensitive isoforms of protein kinase C are not in-
volved in ATP-induced inhibition of Naq, Kq, Cly
cotransport. The role of GTP-binding proteins, cell
volume, intracellular Ca2q and monovalent ions in
the regulation of Naq, Kq, Cly cotransport by
purinoceptors is currently being studied in our labora-
tory.
In terminals of the central and peripheral nervous
systems, ATP and other P agonists are colocalized2
with more specific neurotransmitters, such as cate-
cholamines and acetylcholine. Local hypoxia and in-
jury are another source of ATP release leading to
w xpurinergic activation 41 . We propose that P recep-2
tor-mediated inhibition of Naq, Kq, Cly cotransport,
revealed for the first time in mammalian cells in this
study, may be involved in the regulation of renal
function under normal and pathophysiological condi-
tions.
Screening the cDNA library obtained from differ-
ent organs and species permitted cloning of 2 forms
of Naq, Kq, Cly cotransporters: NKCC1 and
NKCC2. NKCC1 was revealed in all types of cells
studied so far, whereas NKCC2 was selectively ex-
pressed in apical membranes of renal epithelial cells
 w x.for recent comparative analysis, see 42 . The site-
specific effect of SAD on Kq transport across the
w xbasolateral surface of the MDCK monolayer 13,43
indicates that the housekeeping NKCC1 is the major
isoform expressed in these cells. Thus, it may be
suggested that the lack of drastic inhibition of NKCC1
in other non-epithelial and epithelial cells by PMA
and ATP compared with MDCK cells is caused by
tubular segment-specific post-translation modification
of NKCC1 or by a specific set of regulators which
are involved in transduction of purinoceptor-induced
signals to the transporter.
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